Accessibility Tools

2022 ISSLS Research Grant Winner

The winner of the 2022 ISSLS Research Grant Award is Frances Bach from the Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

Title: The effect of notochordal extracellular vesicles on human and bovine nucleus pulpous explants.

The Research Grant Committee would like to congratulate Dr Bach and her co-authors for their outstanding submission.


Purpose: To promote research in the lumbar spine.

Description: The research proposal can be in basic science, biomechanics or clinical science. It will be judged on significance, quality of the hypothesis, experimental protocol and feasibility. Projects that intend to use the ISSLS funding to lead to other, larger funding sources are encouraged but must have a strong plan for further funding. The winning proposal will receive a US$20,000.00 award. The principal investigator must be less than 45 years of age. At least one investigator must be an ISSLS member. The research funds cannot be used as a salary for any of the investigators. The recipient will provide a progress report to the research committee in writing, prior to the annual meeting and present this report at the Fellowship Ceremony.

Funding:

The ISSLS Research Grant has been sponsored by Taisho Toyama Pharmaceuticals for US$20,000 per year. Research costs, only, will be covered by the award. No indirect/overhead costs will be covered by the award.

The current funding for the grant has now ceased and ISSLS is seeking future support to continue this award into the future.

Research Grant Committee:

Secretary of ISSLS – Jeffrey Lotz (Chair)
ISSLS President – Tim Yoon
1st Vice President – Kazuhiro Chiba
2nd Vice President – Peter Robertson
Scientific Representatives – Christy Tomkins-Lane, Hiroshi Hashizume and Karin Wuertz

Proposal Format:

  • Background, Identification of Critical Lack of Knowledge, Preliminary Data, Significance, Hypothesis, Specific Aims: 2 page limit
  • Detailed Experimental Protocol to achieve each specific aim with expected findings and possible interpretations, pitfalls: 5 page limit
  • Further funding plans: 1 page limit
  • Reference: No limit
  • Brief biography indicating the qualifications to perform the research of Principal Investigator and all Co-investigators (1 page limit per person).
  • CV of PI and Co-investigators should be included.

There is currently no funding for this award.  If funding is secured for 2023, an announcement will be made on this page.

E-mail the application to the ISSLS Administrative office fiona.strain@issls.org. Deadline for applications: TO BE ANNOUNCED

Previous winners

  • 2020: Dr Graciosa P. Teixeira, Institute of Orthopaedic Research and Biomechanics, Ulm University, Ulm, Germany.
    Title: Does complement deficiency influence intervertebral disc phenotype? Insights from C6 and CD59 deficient mice organ culture investigations. Read Report
  • 2019: Dr Olga Krupkova, Laboratory for Immunoengineering and Regenerative Medicine, Zurich, Switzerland.
    Title: “Cell-based delivery of GDF-5 for regeneration of the intervertebral disc using CRISPR”. Read Report
    Due to the cancellation of the 2020 Annual Meeting, this report will be available following the 2021 Virtual Annual Meeting.
  • 2018: Hugo Massé-Alarie, The University of Queensland, Australia. Read Final Report, Read Progress Report
Sponsors

With sincere appreciation, the International Society for the Study of the Lumbar Spine thanks the following companies for their sponsorship of the 48th ISSLS Annual Meeting in Boston, USA

ISSLS thanks the following exhibitors for their support at the 48th Annual Meeting in Boston, USA